We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Acquisition Method Expands MS Range and Sampling Depth

By LabMedica International staff writers
Posted on 31 May 2018
Print article
Image: The LTQ Orbitrap XL hybrid ion trap mass spectrometer (Photo courtesy of Thermo Fisher Scientific).
Image: The LTQ Orbitrap XL hybrid ion trap mass spectrometer (Photo courtesy of Thermo Fisher Scientific).
A major challenge for proteomics, particularly in studies using complex samples with high dynamic ranges, is that only a small proportion of peptides in a sample are selected for analysis.

This means that high-abundance peptides are overwhelmingly selected for, making identification and quantification of lower-abundance molecules challenging and highly variable across different samples. One approach to tackling this problem is improving MS2-level analysis by developing methods capable of fragmenting and analyzing a higher proportion of the precursor ions introduced into the mass spectrometer (MS).

Scientists at the Max Planck Institute of Biochemistry (Martinsried, Germany) developed an approach, named the BoxCar acquisition method that adjusts the sampling of ions at the MS1 level during MS analysis to expand the instrument's dynamic range and sampling depth. This approach significantly boosts the sensitivity and reproducibility of conventional data-dependent MS acquisition.

In the BoxCar method, the team focused on this MS1 level, and the limitations of the ion storage device (C-trap) used in some of Orbitrap instruments, specifically. In these instruments, ions are generated by electrospray and then passed into the C-trap before moving into the Orbitrap for analysis. However, according to the authors, the C-trap can store only one million charges at a time, which, they noted, is around 1% of the ions generated during its fill time, meaning that around 99% of ions generated are never analyzed. Because high-abundance ions are overrepresented in the overall sample, they will also be overrepresented in the 1% of the ions that are ultimately analyzed, crowding out lower-abundance molecules.

The investigators applied the method to human plasma and found that it provided an additional order of magnitude of dynamic range, a notable boost in performance, given that plasma can exceed ten orders of dynamic range. They also found it helped substantially with the "missing data" problem that has limited the usefulness of shotgun proteomics in work like clinical biomarker research, where reproducible quantification across large numbers of samples is key. In an analysis of 10 HeLa cell digests using 45-minute MS runs, the scientists found the BoxCar method quantified 7,222 proteins per run, 6,216 of which were quantified in all 10 runs. An equivalent study using a conventional shotgun method quantified 5,050 proteins, 4,180 of them in all 10 runs. In one hour analyses, the method provided MS1-level evidence for more than 90% of the proteome of a human cancer cell line that had previously been identified in 24 fractions.

Florian Meier, MSc, the lead author of the study, said, “It's now no longer a big deal to generate a very deep library of a sample by fractionating. If you have a lot of samples, then the time you spend on generating libraries is not a lot compared to the time you can spend on actually quantifying your samples. That's the workflow we have set up for clinical samples in particular.” The study was published on May 7, 2018, in the journal Nature Methods.

Related Links:
Max Planck Institute of Biochemistry

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.